… ‐controlled trial of the once‐daily GLP‐1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a …
… diabetes (who tend to have a pathophysiology of insulin deficiency rather than insulin resistance… patients (the remainder were of Chinese or Indian origin), looked at liraglutide add-on to …..... Read More